{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:15:04Z","timestamp":1790673304506,"version":"4.1.0"},"reference-count":102,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T00:00:00Z","timestamp":1639008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Sarcoidosis is a multi-system inflammatory disease characterized by the development of inflammation and noncaseating granulomas that can involve nearly every organ system, with a predilection for the pulmonary system. Cardiac involvement of sarcoidosis (CS) occurs in up to 70% of cases, and accounts for a significant share of sarcoid-related mortality. The clinical presentation of CS can range from absence of symptoms to conduction abnormalities, heart failure, arrhythmias, valvular disease, and sudden cardiac death. Given the significant morbidity and mortality associated with CS, timely diagnosis is important. Traditional imaging modalities and histologic evaluation by endomyocardial biopsy often provide a low diagnostic yield. Cardiac positron emission tomography (PET) has emerged as a leading advanced imaging modality for the diagnosis and management of CS. This review article will summarize several aspects of the current use of PET in CS, including indications for use, patient preparation, image acquisition and interpretation, diagnostic and prognostic performance, and evaluation of treatment response. Additionally, this review will discuss novel PET radiotracers currently under study or of potential interest in CS.<\/jats:p>","DOI":"10.3390\/ph14121286","type":"journal-article","created":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T21:46:58Z","timestamp":1639086418000},"page":"1286","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["PET Imaging in Cardiac Sarcoidosis: A Narrative Review with Focus on Novel PET Tracers"],"prefix":"10.3390","volume":"14","author":[{"given":"Petar","family":"Saric","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Young","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8267-7020","authenticated-orcid":false,"given":"Martin","family":"Rodriguez-Porcel","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panithaya","family":"Chareonthaitawee","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,12,9]]},"reference":[{"key":"ref_1","first-page":"736","article-title":"Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999","volume":"160","author":"Hunninghake","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1513\/AnnalsATS.201508-568BC","article-title":"Epidemiology of sarcoidosis in a prospective cohort study of U.S. women","volume":"13","author":"Dumas","year":"2016","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.rmed.2012.02.007","article-title":"Unexpectedly high prevalence of sarcoidosis in a repre-sentative U.S. metropolitan population","volume":"106","author":"Erdal","year":"2012","journal-title":"Respir. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.ccm.2015.08.008","article-title":"Cardiac Sarcoidosis","volume":"36","author":"Birnie","year":"2015","journal-title":"Clin. Chest Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/01.CIR.58.6.1204","article-title":"Cardiac sarcoid: A clinicopathologic study of 84 unselected patients with systemic sarcoidosis","volume":"58","author":"Silverman","year":"1978","journal-title":"Circulation"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1378\/chest.103.1.253","article-title":"Myocardial sarcoidosis","volume":"103","author":"Sharma","year":"1993","journal-title":"Chest"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1749-6632.1976.tb47058.x","article-title":"Clinicopathological study on fatal myocardial sarcoidosis","volume":"278","author":"Matsui","year":"1976","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1136\/hrt.2005.080481","article-title":"Cardiac sarcoidosis","volume":"92","author":"Doughan","year":"2006","journal-title":"Heart"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.5858\/2009-0274-RA.1","article-title":"Cardiac sarcoidosis: A pathology-focused review","volume":"134","author":"Lagana","year":"2010","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.amjcard.2009.03.068","article-title":"Comparison of necropsy findings in patients with sarcoidosis dying suddenly from cardiac sarcoidosis versus dying suddenly from other causes","volume":"104","author":"Tavora","year":"2009","journal-title":"Am. J. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2143\/AC.65.1.2045894","article-title":"Sarcoidosis: An unusual cause of acute pericarditis","volume":"65","author":"Wyplosz","year":"2010","journal-title":"Acta Cardiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.pcad.2009.11.010","article-title":"Diagnosis and management of cardiac sarcoidosis","volume":"52","author":"Dubrey","year":"2010","journal-title":"Prog. Cardiovasc. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1161\/CIRCULATIONAHA.110.990747","article-title":"Coronary artery vasculitis as a presentation of cardiac sarcoidosis","volume":"125","author":"Ward","year":"2012","journal-title":"Circulation"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1136\/bmj.292.6528.1095","article-title":"Sarcoid heart disease","volume":"292","author":"Fleming","year":"1986","journal-title":"Br. Med. J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0002-9343(77)90121-8","article-title":"Sarcoidosis of the heart","volume":"63","author":"Roberts","year":"1977","journal-title":"Am. J. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1378\/chest.128.1.30","article-title":"Cardiac involvement in patients with pulmonary sarcoidosis assessed at two university medical centers in the Netherlands","volume":"128","author":"Smedema","year":"2005","journal-title":"Chest"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0002-9149(01)01978-6","article-title":"Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone","volume":"88","author":"Yazaki","year":"2001","journal-title":"Am. J. Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/europace\/eun110","article-title":"Ventricular tachyarrhythmia as a primary presentation of sarcoidosis","volume":"10","author":"Uusimaa","year":"2008","journal-title":"Europace"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2796.2011.02396.x","article-title":"Diagnosing isolated cardiac sarcoidosis","volume":"270","author":"Kandolin","year":"2011","journal-title":"J. Intern. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1007\/s12350-016-0658-1","article-title":"Isolated cardiac sarcoidosis: A focused review of an under-recognized entity","volume":"25","author":"Okada","year":"2018","journal-title":"J. Nucl. Cardiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s11886-014-0514-3","article-title":"Cardiac sarcoidosis","volume":"16","author":"Zipse","year":"2014","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.amjcard.2004.08.083","article-title":"Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis","volume":"95","author":"Chiu","year":"2005","journal-title":"Am. J. Cardiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s10741-012-9358-3","article-title":"Idiopathic giant cell myocarditis and cardiac sarcoidosis","volume":"18","author":"Blauwet","year":"2013","journal-title":"Heart Fail. Rev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s12350-009-9110-0","article-title":"Effectiveness of prolonged fasting 18f-FDG PET-CT in the detection of cardiac sarcoidosis","volume":"16","author":"Langah","year":"2009","journal-title":"J. Nucl. Cardiol."},{"key":"ref_25","first-page":"1030","article-title":"Identification of cardiac sarcoidosis with (13)N-NH(3)\/(18)F-FDG PET","volume":"44","author":"Yamagishi","year":"2003","journal-title":"J. Nucl. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1093\/eurheartj\/ehi180","article-title":"Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis\u2020","volume":"26","author":"Ishimaru","year":"2005","journal-title":"Eur. Heart J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2967\/jnumed.111.090662","article-title":"The Use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: A systematic review and metaanalysis including the Ontario experience","volume":"53","author":"Youssef","year":"2012","journal-title":"J. Nucl. Med."},{"key":"ref_28","unstructured":"Hiraga, H., and Iwai, K. (1993). Guidelines for Diagnosis of Cardiac Sarcoidosis: Study Report on Diffuse Pulmonary Disease."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"42","DOI":"10.17996\/anc.17-00042","article-title":"New guidelines for diagnosis of cardiac sarcoidosis in Japan","volume":"3","author":"Terasaki","year":"2017","journal-title":"Ann. Nucl. Cardiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2967\/jnumed.117.196287","article-title":"Joint SNMMI\u2013ASNC expert consensus document on the role of 18F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring","volume":"58","author":"Chareonthaitawee","year":"2017","journal-title":"J. Nucl. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0033-0620(89)90027-3","article-title":"Myocardial metabolism in ischemic heart disease: Basic principles and application to imaging by positron emission tomography","volume":"32","author":"Camici","year":"1989","journal-title":"Prog. Cardiovasc. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"80S","DOI":"10.2967\/jnumed.109.068205","article-title":"Tracing cardiac metabolism in vivo: One substrate at a time","volume":"51","author":"Taegtmeyer","year":"2010","journal-title":"J. Nucl. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s12350-015-0226-0","article-title":"The effects of 18-h fasting with low-carbohydrate diet preparation on suppressed physiological myocardial 18F-fluorodeoxyglucose (FDG) uptake and possible minimal effects of unfractionated heparin use in patients with suspected cardiac involvement sarcoidosis","volume":"23","author":"Manabe","year":"2016","journal-title":"J. Nucl. Cardiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1177\/0284185115600916","article-title":"Administration of unfractionated heparin with prolonged fasting could reduce physiological 18F-fluorodeoxyglucose uptake in the heart","volume":"57","author":"Masuda","year":"2016","journal-title":"Acta Radiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2191-219X-4-1","article-title":"Long fasting is effective in inhibiting physiological myocardial 18F-FDG uptake and for evaluating active lesions of cardiac sarcoidosis","volume":"4","author":"Morooka","year":"2014","journal-title":"EJNMMI Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1007\/s12350-011-9422-8","article-title":"Utility of high fat and low carbohydrate diet in suppressing myocardial FDG uptake","volume":"18","author":"Harisankar","year":"2011","journal-title":"J. Nucl. Cardiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s12350-016-0502-7","article-title":"Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation","volume":"24","author":"Osborne","year":"2017","journal-title":"J. Nucl. Cardiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1365-2125.1979.tb01000.x","article-title":"A dose-response study of the anticoagulant and lipolytic activities of heparin in normal subjects","volume":"7","author":"Asmal","year":"1979","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1007\/s12350-013-9798-8","article-title":"Complete somatostatin-induced insulin suppression combined with heparin loading does not significantly suppress myocardial 18F-FDG uptake in patients with suspected cardiac sarcoidosis","volume":"20","author":"Gormsen","year":"2013","journal-title":"J. Nucl. Cardiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s12350-019-01746-4","article-title":"Suppressing physiologic 18-fluorodeoxyglucose uptake in patients undergoing positron emission tomography for cardiac sarcoidosis: The effect of a structured patient preparation protocol","volume":"28","author":"Christopoulos","year":"2021","journal-title":"J. Nucl. Cardiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s12350-016-0522-3","article-title":"ASNC imaging guidelines\/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures","volume":"23","author":"Dilsizian","year":"2016","journal-title":"J. Nucl. Cardiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.2967\/jnumed.111.092726","article-title":"Performance measurements of the Siemens mMR integrated whole-body PET\/MR scanner","volume":"52","author":"Delso","year":"2011","journal-title":"J. Nucl. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.2967\/jnumed.107.039792","article-title":"Frequent diagnostic errors in cardiac PET\/CT due to misregistration of CT attenuation and emission PET images: A definitive analysis of causes, consequences, and corrections","volume":"48","author":"Gould","year":"2007","journal-title":"J. Nucl. Med."},{"key":"ref_45","first-page":"436","article-title":"Do implanted pacemaker leads and ICD leads cause metal-related artifact in cardiac PET\/CT?","volume":"46","author":"DiFilippo","year":"2005","journal-title":"J. Nucl. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1007\/s12350-018-01504-y","article-title":"The prognostic value of quantitating and localizing F-18 FDG uptake in cardiac sarcoidosis","volume":"27","author":"Flores","year":"2020","journal-title":"J. Nucl. Cardiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s12350-018-01582-y","article-title":"Diagnostic performance of F-18 FDG PET for detection of cardiac sarcoidosis; A systematic review and meta-analysis","volume":"27","author":"Kim","year":"2020","journal-title":"J. Nucl. Cardiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","article-title":"Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis","volume":"63","author":"Blankstein","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s12350-014-9901-9","article-title":"Quantitative interpretation of FDG PET\/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis","volume":"21","author":"Ahmadian","year":"2014","journal-title":"J. Nucl. Cardiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1007\/s00259-018-4001-8","article-title":"Prognostic role of serial quantitative evaluation of 18F-fluorodeoxyglucose uptake by PET\/CT in patients with cardiac sarcoidosis presenting with ventricular tachycardia","volume":"45","author":"Muser","year":"2018","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13550-017-0315-y","article-title":"Semi-quantitative metabolic values on FDG PET\/CT including extracardiac sites of disease as a predictor of treatment course in patients with cardiac sarcoidosis","volume":"7","author":"Ishiyama","year":"2017","journal-title":"EJNMMI Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jcmg.2017.04.020","article-title":"Prognostic impact of extent, severity, and heterogeneity of abnormalities on 18F-FDG PET scans for suspected cardiac sarcoidosis","volume":"11","author":"Sperry","year":"2018","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.jcmg.2020.11.016","article-title":"and Narasimhan, C. Pre-treatment myocardial 18FDG uptake predicts response to immunosup-pression in patients with cardiac sarcoidosis","volume":"14","author":"Subramanian","year":"2021","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12350-013-9828-6","article-title":"Reduction in 18F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis","volume":"21","author":"Osborne","year":"2014","journal-title":"J. Nucl. Cardiol."},{"key":"ref_55","first-page":"133","article-title":"Efficacy of corticosteroids in sarcoidosis presenting with atrioventricular block","volume":"20","author":"Kato","year":"2003","journal-title":"Sarcoidosis Vasc. Diffus. Lung Dis. Off. J. WASOG"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ijcard.2018.11.131","article-title":"Treatment of cardiac sarcoidosis: A comparative study of steroids and steroids plus immunosuppressive drugs","volume":"276","author":"Ballul","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.cardfail.2019.02.018","article-title":"Serial cardiac FDG-PET for the diagnosis and therapeutic guidance of patients with cardiac sarcoidosis","volume":"25","author":"Ning","year":"2019","journal-title":"J. Card. Fail."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijcard.2021.02.022","article-title":"Effectiveness and safety of infliximab in cardiac sarcoidosis","volume":"330","author":"Bakker","year":"2021","journal-title":"Int. J. Cardiol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Elwazir, M., Krause, M.L., Bois, J.P., Christopoulos, G., Kendi, A.T., Cooper, J.L.T., Jouni, H., Abouezzeddine, O.F., Chareonthaitawee, P., and Abdelshafee, M. (2021). Rituximab for the treatment of refractory cardiac sarcoidosis: A single-center experience. J. Cardiac Fail., online ahead of print.","DOI":"10.1016\/j.cardfail.2021.07.008"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s12350-018-1356-y","article-title":"Emerging imaging targets for infiltrative cardiomyopathy: Inflammation and fibrosis","volume":"26","author":"Bengel","year":"2019","journal-title":"J. Nucl. Cardiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1053\/j.semnuclmed.2006.03.007","article-title":"Imaging of neuroendocrine tumors","volume":"36","author":"Rufini","year":"2003","journal-title":"Semin. Nucl. Med."},{"key":"ref_62","first-page":"21","article-title":"Somatostatin receptor scintigraphy and gallium scintigraphy in patients with sarcoidosis","volume":"42","author":"Lebtahi","year":"2001","journal-title":"J. Nucl. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1007\/s002590050297","article-title":"Somatostatin receptor imaging in patients with sarcoidosis","volume":"25","author":"Kwekkeboom","year":"1998","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_64","first-page":"426","article-title":"The value of 68Ga-DOTATATE PET\/CT in diagnosis and management of neuroendocrine tumors compared to current FDA approved imaging modalities: A review of literature","volume":"4","author":"Mojtahedi","year":"2014","journal-title":"Am. J. Nucl. Med. Mol. Imaging"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13550-016-0207-6","article-title":"A dual tracer 68Ga-DOTANOC PET\/CT and 18F-FDG PET\/CT pilot study for detection of cardiac sarcoidosis","volume":"6","author":"Gormsen","year":"2016","journal-title":"EJNMMI Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"77807","DOI":"10.18632\/oncotarget.12799","article-title":"Somatostatin receptor based PET\/CT in patients with the suspicion of cardiac sarcoidosis: An initial comparison to cardiac MRI","volume":"7","author":"Lapa","year":"2016","journal-title":"Oncotarget"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s12350-019-01782-0","article-title":"Feasibility of somatostatin receptor-targeted imaging for detection of myocardial inflammation: A pilot study","volume":"28","author":"Bravo","year":"2021","journal-title":"J. Nucl. Cardiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/3337","article-title":"Imaging proliferation in vivo with [F-18]FLT and positron emission tomography","volume":"4","author":"Shields","year":"1998","journal-title":"Nat. Med."},{"key":"ref_69","first-page":"695","article-title":"and Elsinga, P.H. Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from in-flammation in a rodent model","volume":"45","author":"Cobben","year":"2004","journal-title":"J. Nucl. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"8350","DOI":"10.1016\/S0021-9258(18)68484-4","article-title":"Regulation of human thymidine kinase during the cell cycle","volume":"263","author":"Sherley","year":"1988","journal-title":"J. Biol. Chem."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2967\/jnumed.107.044578","article-title":"Usefulness of 11C-Methionine for differentiating tumors from granulomas in experimental rat models: A comparison with 18F-FDG and 18F-FLT","volume":"49","author":"Zhao","year":"2008","journal-title":"J. Nucl. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12410-018-9446-4","article-title":"Molecular imaging of cardiac sarcoidosis","volume":"11","author":"Martineau","year":"2018","journal-title":"Curr. Cardiovasc. Imaging Rep."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13550-017-0321-0","article-title":"Comparative evaluation of 18F-FLT and 18F-FDG for detecting cardiac and extra-cardiac thoracic involvement in patients with newly diagnosed sarcoidosis","volume":"7","author":"Norikane","year":"2017","journal-title":"EJNMMI Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s13550-020-00742-x","article-title":"FLT-PET for the assessment of systemic sarcoidosis including cardiac and CNS involvement: A prospective study with comparison to FDG-PET","volume":"10","author":"Martineau","year":"2020","journal-title":"EJNMMI Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/j.jcmg.2019.06.020","article-title":"Imaging cardiac sarcoidosis with FLT-PET compared with FDG\/Perfusion-PET","volume":"12","author":"Martineau","year":"2019","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/RLU.0000000000000303","article-title":"18F-Choline PET\/CT Pitfalls in Image Interpretation: An update on 300 examined patients with prostate cancer","volume":"39","author":"Calabria","year":"2014","journal-title":"Clin. Nucl. Med."},{"key":"ref_77","first-page":"1663","article-title":"In prostate cancer (PC) patients, PET-CT-18F-choline (FC) can incidentally discover unrelated diseases: Our experience in 573 cases","volume":"55","author":"Rensi","year":"2014","journal-title":"J. Nucl. Med."},{"key":"ref_78","first-page":"63","article-title":"Incidental detection and monitoring of spontaneous recovery of sarcoidosis via fluorine-18-fluoroethyl-choline positron emission tomography\/computed tomography","volume":"15","author":"Takesh","year":"2012","journal-title":"Hell. J. Nucl. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s12350-020-02069-5","article-title":"Proliferation imaging with 11C-4DST PET\/CT for the evaluation of cardiac sarcoidosis, compared with FDG-PET\/CT given a long fasting preparation protocol","volume":"28","author":"Minamimoto","year":"2021","journal-title":"J. Nucl. Cardiol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/RLU.0000000000002059","article-title":"11C-4DST PET\/CT imaging of cardiac sarcoidosis: Comparison with 18F-FDG and cardiac MRI","volume":"43","author":"Hotta","year":"2018","journal-title":"Clin. Nucl. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0360-3016(96)00325-2","article-title":"Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: A pretherapy study of 37 patients","volume":"36","author":"Rasey","year":"1996","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1161\/01.RES.67.1.240","article-title":"Fluoromisonidazole: A metabolic marker of myocyte hypoxia","volume":"67","author":"Martin","year":"1990","journal-title":"Circ. Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/bjc.1981.79","article-title":"A marker for hypoxic cells in tumours with potential clinical applicability","volume":"43","author":"Chapman","year":"1981","journal-title":"Br. J. Cancer"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0006-2952(86)90565-4","article-title":"The biological properties of reduced nitroheterocyclics and possible underlying biochemical mechanisms","volume":"35","author":"Whitmore","year":"1986","journal-title":"Biochem. Pharmacol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/5584_2015_144","article-title":"Expression of HIF-1A\/VEGF\/ING-4 Axis in pulmonary sarcoidosis","volume":"866","author":"Piotrowski","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1007\/s12350-019-01976-6","article-title":"18F-FMISO PET\/CT detects hypoxic lesions of cardiac and extra-cardiac involvement in patients with sarcoidosis","volume":"28","author":"Furuya","year":"2021","journal-title":"J. Nucl. Cardiol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1053\/j.semnuclmed.2007.08.004","article-title":"18F-Labeled Positron Emission Tomographic Radiopharmaceuticals in Oncology: An Overview of Radiochemistry and Mechanisms of Tumor Localization","volume":"37","author":"Vallabhajosula","year":"2007","journal-title":"Semin. Nucl. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1161\/ATVBAHA.110.221440","article-title":"Detection of hypoxia by [18F]EF5 in ath-erosclerotic plaques in mice","volume":"31","author":"Silvola","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ijrobp.2014.09.045","article-title":"A comparative study of the hypoxia PET tracers [18F]HX4, [18F]FAZA, and [18F]FMISO in a preclinical tumor model","volume":"91","author":"Peeters","year":"2015","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_90","first-page":"1160","article-title":"Fluorine-18-fluorodeoxyglucose and carbon-11-methionine evaluation of lymphadenopathy in sarcoidosis","volume":"39","author":"Yamada","year":"1998","journal-title":"J. Nucl. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/01.rlu.0000134997.91642.56","article-title":"C\u201311 methionine uptake in granulomatous disease","volume":"29","author":"Hain","year":"2004","journal-title":"Clin. Nucl. Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/01.rlu.0000222735.19513.bb","article-title":"Combined C-11 methionine and F-18 FDG PET imaging in a case of neurosarcoidosis","volume":"31","author":"Ng","year":"2006","journal-title":"Clin. Nucl. Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.2967\/jnumed.116.174045","article-title":"11C-methionine PET of myocardial inflammation in a rat model of experimental autoimmune myocarditis","volume":"57","author":"Maya","year":"2016","journal-title":"J. Nucl. Med."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.2174\/092986710791959792","article-title":"CXCR4-CXCL12-dependent inflammatory network and endothelial progenitors","volume":"17","author":"Salvatore","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"ref_95","first-page":"212","article-title":"The CXCL12\/CXCR4 chemokine ligand\/receptor axis in cardiovascular disease","volume":"5","author":"Doring","year":"2014","journal-title":"Front. Physiol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"618","DOI":"10.7150\/thno.11251","article-title":"Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imaging","volume":"5","author":"Wester","year":"2015","journal-title":"Theranostics"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.2967\/jnumed.111.098798","article-title":"PET of CXCR4 expression by a 68Ga-labeled highly specific targeted contrast agent","volume":"52","author":"Gourni","year":"2011","journal-title":"J. Nucl. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2967\/jnumed.117.196485","article-title":"Clinical molecular imaging of chemokine receptor CXCR4 expression in atherosclerotic plaque using 68Ga-pentixafor PET: Correlation with Cardiovascular risk factors and calcified plaque burden","volume":"59","author":"Weiberg","year":"2018","journal-title":"J. Nucl. Med."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.jcmg.2015.09.008","article-title":"Molecular imaging of the chemokine receptor CXCR4 after acute myocardial infarction","volume":"8","author":"Thackeray","year":"2015","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.jcmg.2018.01.001","article-title":"Imaging of C-X-C motif chemokine receptor CXCR4 expression after myocardial infarction with [68Ga]pentixafor-PET\/CT in correlation with cardiac MRI","volume":"11","author":"Reiter","year":"2018","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"e639","DOI":"10.1161\/CIRCULATIONAHA.112.001217","article-title":"Active cardiac sarcoidosis: First clinical experience of simultaneous positron emission tomography-magnetic resonance imaging for the diagnosis of cardiac disease","volume":"127","author":"White","year":"2013","journal-title":"Circulation"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jcmg.2016.09.023","article-title":"Myocardial blood flow and inflammatory cardiac sarcoidosis","volume":"10","author":"Kruse","year":"2017","journal-title":"JACC Cardiovasc. Imaging"}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/14\/12\/1286\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:44:06Z","timestamp":1760168646000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/14\/12\/1286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,9]]},"references-count":102,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["ph14121286"],"URL":"https:\/\/doi.org\/10.3390\/ph14121286","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,9]]}}}